World Congress on Bioavailability & Bioequivalence

August 06-07, 2018 ∣ Tokyo, Japan

 

Conference full name: World Congress on Bioavailability & Bioequivalence(BA/BE Studies Summit)

Short name: BABE 2018

Theme: BA/BE: Essential Innovation in Contemporary Studies

 

About conference

Meeting international proudly announces the “World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit” which will be held during August 06-07, 2018 at Tokyo, Japan. The theme of conference is “BA/BE: Essential Innovation in Contemporary Studies”. BABE 2018 mainly focuses on Bioavailability & Bioequivalence, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of drug development with obvious applications in Drug discovery, Pharmacogenomics, Clinical trials, Pharmaceuticals Formulation, Pharmacokinetics and Pharmacology and Computer-aided drug design, diagnosis, and disease management.

 

URL: http://www.meetingsint.com/conferences/bioavailability-bioequivalence

Abstract submission:
http://www.meetingsint.com/conferences/bioavailability-bioequivalence/abstract-submission

Registration link:
http://www.meetingsint.com/conferences/bioavailability-bioequivalence/registration

 

Conference highlights.

• Emerging Bioavailability & Bioequivalence Studies
• Advances in BA&BE
• BA/BE of Biologic & Biosimilar
• Drug Metabolism
• Natural Products in Drug Discovery and Development
• Bioequivalence Protocol: In-Vitro / In-Vivo Studies
• Biopharmaceutics Applications & Clinical Pharmacology
• Pharmaceuticals Formulation
• Pharmacology: PK & PD approach
• Biowaivers: Criteria
• Recent Advancement in BA/BE Research
• Regulatory Requirement and Approaches
• Pharmaceuticals Industry: Entrepreneur Meet

 

Contact address:

Best Regards
Richardson Brown
Program Manager: BABE-2018
28 Maxwell Road, #03-05 Red Dot Traffic,
Singapore (069120)
Email: babe@annualmeet.org     
Phone: +6531080483; +1-302-231-6756
Toll Free: +800-852-6126